Quarterly report pursuant to Section 13 or 15(d)

Revision of Prior Period Financial Statements - Revised Condensed Consolidated Statements of Cash Flows (Details)

v3.22.2.2
Revision of Prior Period Financial Statements - Revised Condensed Consolidated Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:                      
Net loss $ (18,615) $ (25,686) $ (13,801) $ 20,807 $ (22,977) $ (13,506) $ (36,483) $ (58,102) $ (15,676) $ (10,888) $ (28,427)
Adjustments to reconcile net loss to net cash used in operating activities:                      
Depreciation and amortization 1,400   1,086 800   452 1,102 3,782 1,948 2,895 1,065
Write-off of inventory     324         559 400 2,132  
Adjustment to property and equipment for sales type leases     (625)         (625) 0 (91)  
Loss from impairment of property and equipment 626   96 1,656       1,038 1,656 1,869  
Loss on disposal of property and equipment               0 659 617  
Stock-based compensation     3,927     309 1,376 15,513 6,032 9,596 1,579
Non-cash interest expense     5     2,344 5,455 14 5,561 5,245 25
Non-cash lease expense     197         602 0    
Provision recorded for allowance for doubtful accounts           (63) (63) 100 (63) (13) 47
Loss on extinguishment of debt 0     865 11,820   11,820 0 12,685 12,685 66
Change in fair value of derivative liability 0     (475) 795 1,425 2,220 0 1,745 1,745  
Change in fair value of common stock warrant liability 0     (42) 185 736 921 0 879 879  
Change in fair value of contingent earn-out liability (7,245)   (3,078) (32,609)       (9,754) (32,609) (47,360)  
Change in fair value of contingently issuable common stock liability (1,081)   (1,472) (5,718)       (2,529) (5,718) (6,406)  
Change in fair value of public warrant liability 1,146   (5,586) (3,152)       (4,297) (3,152) (12,606)  
Changes in operating assets and liabilities                      
Accounts receivable     (2,112)     (874) (1,335) (14,822) (5,866) (5,063) (464)
Inventory     (1,310)     (480) (453) (4,401) (736) (3,436) (315)
Commission assets     (351)     (391) (742) (1,656) (1,102) (3,072) (1,785)
Contract assets     108     (119) (239) (1,938) (3,477) (4,877)  
Other assets     141     7 13 (629) 23 32 (173)
Prepaid expenses and other current assets     (5,571)     (3,727) (7,287) (9,009) (11,535) (9,148) (1,016)
Accounts payable     (855)     959 3,499 2,177 240 765 815
Deferred revenue     2,577     (806) 153 16,005 2,352 4,832 2,386
Deferred rent     0     (11) 152 0 397 457 (34)
Warranty reserve             (42) 0 (42) (42) (14)
Accrued expenses and other current liabilities           1,306 1,641   2,834 2,472 2,643
Accrued expenses and other current liabilities     (2,433)         (750) 2,834    
Operating lease liability     (697)         (699) 0   0
Net cash used in operating activities     (29,430)     (12,439) (18,292) (69,421) (42,565) (56,781) (23,602)
Cash flows from investing activities:                      
Development of internal-use software     (728)         (1,936) 0 (1,028)  
Purchases of property and equipment     (6,689)     (2,121) (7,954) (17,554) (10,994) (16,557) (6,261)
Net cash used in investing activities     (7,417)     (2,121) (7,954) (19,178) (10,994) (17,585) (6,261)
Cash flows from financing activities:                      
Proceeds from issuance of Series B-1 convertible preferred stock, net of issuance costs                     2,994
Proceeds from exercise of stock options     227     455 657 571 777 915 442
Proceeds from issuance of common stock from the PIPE Investment               0 300,000 300,000  
Proceeds from the closing of the Merger               0 84,945 84,945  
Payment of offering costs from the closing of the Merger and PIPE Investment               0 (33,968) (34,132)  
Repayment of financing obligations           (359) (359) 0 (359) (359) (244)
Proceeds from long-term debt, net of issuance costs           31,882 31,882 0 31,882 31,882 22,438
Repayment of principal on long-term debt               (1,000) 0 (5,422) (8,404)
Net cash provided by (used in) financing activities     227     31,978 32,180 (429) 383,277 377,829 17,226
Effect of exchange rate changes on cash and cash equivalents               35 0    
Net increase (decrease) in cash, cash equivalents and restricted cash     (36,620)     17,418 5,934 (88,993) 329,718 303,463 (12,637)
Cash, cash equivalents and restricted cash                      
Cash, cash equivalents and restricted cash at beginning of period   271,547 308,167 10,638 22,122 4,704 4,704 308,167 4,704 4,704 17,341
Cash, cash equivalents and restricted cash at end of period $ 219,174   271,547 334,422 10,638 22,122 10,638 219,174 334,422 308,167 4,704
Supplemental disclosure of cash flow information                      
Transfer of inventory to property and equipment     0       46   0 0 86
Capital expenditures incurred but not yet paid     2,391     1,335 2,962 5,935 3,123 2,936 1,100
Capitalization of stock compensation             27 90 40    
Issuance of equity classified warrants         0 1       0 112
Deferred offering costs included in accounts payable               0 1,770 1,943  
Conversion of convertible preferred stock to common stock               0 75,877 75,877  
Initial fair value of contingent earn-out liability recognized in connection with the closing of the Merger               0 67,021 67,021  
Initial fair value of contingently issuable common stock liability recognized in connection with the closing of the Merger               0 11,670 11,670  
Conversion of common stock warrants to common stock in connection with the closing of the Merger               0 880 880  
Initial fair value of public warrants in connection with the closing of the Merger               0 23,636 23,636  
Issuance of a nonrecourse promissory note with officer                     350
As Previously Reported                      
Cash flows from operating activities:                      
Net loss     (14,551)   (22,371) (13,755) (36,126)   (13,375) (10,858) (27,392)
Adjustments to reconcile net loss to net cash used in operating activities:                      
Depreciation and amortization     948     452 1,102   1,948 2,895 1,065
Write-off of inventory     324           400 2,132  
Adjustment to property and equipment for sales type leases     (321)             (91)  
Loss from impairment of property and equipment     96 1,656         1,656 1,869  
Loss on disposal of property and equipment                 659 617  
Stock-based compensation     5,190     1,082 1,617   4,013 8,511 662
Non-cash interest expense     5     2,344 5,455   5,561 5,245 25
Non-cash lease expense     197                
Provision recorded for allowance for doubtful accounts           (63) (63)   (63) (13) 47
Loss on extinguishment of debt       865 11,820   11,820   12,685 12,685 66
Change in fair value of derivative liability       (475) 795 1,425 2,220   1,745 1,745  
Change in fair value of common stock warrant liability       (42) 185 736 921   879 879  
Change in fair value of contingent earn-out liability     (4,226) (31,818)         (31,818) (46,212)  
Change in fair value of contingently issuable common stock liability     (1,472) (5,718)         (5,718) (6,406)  
Change in fair value of public warrant liability     (5,586) (3,152)         (3,152) (12,606)  
Changes in operating assets and liabilities                      
Accounts receivable     (2,112)     (874) (1,335)   (5,866) (5,063) (464)
Inventory     (6,985)     (433) (1,173)   (10,836) (17,479) (1,471)
Commission assets     (351)     (391) (742)   (1,102) (3,072) (1,785)
Contract assets     108     (119) (239)   (2,582) (4,877)  
Other assets     0     0 0   0 0 0
Prepaid expenses and other current assets     (5,280)     (4,104) (7,495)   (12,772) (10,079) (375)
Accounts payable     (1,867)     1,194 5,361   2,264 (7) 1,915
Deferred revenue     2,778     (621) 253   2,459 4,968 2,341
Deferred rent     (468)     (11) 152   397 457 (34)
Warranty reserve             (42)   (42) (42) (14)
Accrued expenses and other current liabilities           1,100 1,360   2,183 5,174 2,160
Accrued expenses and other current liabilities     (2,065)                
Operating lease liability     (229)               0
Net cash used in operating activities     (35,867)     (12,038) (16,954)   (50,477) (69,628) (23,254)
Cash flows from investing activities:                      
Development of internal-use software     (646)             (1,028)  
Purchases of property and equipment     (323)     (2,522) (9,292)   (3,082) (3,710) (6,609)
Net cash used in investing activities     (969)     (2,522) (9,292)   (3,082) (4,738) (6,609)
Cash flows from financing activities:                      
Proceeds from issuance of Series B-1 convertible preferred stock, net of issuance costs                     2,994
Proceeds from exercise of stock options     216     455 657   777 915 442
Proceeds from issuance of common stock from the PIPE Investment                 300,000 300,000  
Proceeds from the closing of the Merger                 84,945 84,945  
Payment of offering costs from the closing of the Merger and PIPE Investment                 (33,968) (34,132)  
Repayment of financing obligations           (359) (359)   (359) (359) (244)
Proceeds from long-term debt, net of issuance costs           31,882 31,882   31,882 31,882 22,438
Repayment of principal on long-term debt                   (5,422) (8,404)
Net cash provided by (used in) financing activities     216     31,978 32,180   383,277 377,829 17,226
Net increase (decrease) in cash, cash equivalents and restricted cash     (36,620)     17,418 5,934   329,718 303,463 (12,637)
Cash, cash equivalents and restricted cash                      
Cash, cash equivalents and restricted cash at beginning of period   271,547 308,167 10,638 22,122 4,704 4,704 308,167 4,704 4,704 17,341
Cash, cash equivalents and restricted cash at end of period     271,547 334,422 10,638 22,122 10,638   334,422 308,167 4,704
Supplemental disclosure of cash flow information                      
Transfer of inventory to property and equipment     4,620       46   9,648 12,949 86
Capital expenditures incurred but not yet paid     1,693     0 0   0 347 0
Capitalization of stock compensation             0        
Issuance of equity classified warrants           1       1 112
Deferred offering costs included in accounts payable                 1,760 1,932  
Conversion of convertible preferred stock to common stock                 75,877 75,877  
Initial fair value of contingent earn-out liability recognized in connection with the closing of the Merger                 66,845 67,021  
Initial fair value of contingently issuable common stock liability recognized in connection with the closing of the Merger                 11,670 11,670  
Conversion of common stock warrants to common stock in connection with the closing of the Merger                 880 880  
Initial fair value of public warrants in connection with the closing of the Merger                 23,636 23,636  
Issuance of a nonrecourse promissory note with officer                     350
Adjustment                      
Cash flows from operating activities:                      
Net loss     750   (606) 249 (357)   (2,301) (30) (1,035)
Adjustments to reconcile net loss to net cash used in operating activities:                      
Depreciation and amortization     138     0 0   0 0 0
Write-off of inventory     0           0 0  
Adjustment to property and equipment for sales type leases     (304)             0  
Loss from impairment of property and equipment     0 0         0 0  
Loss on disposal of property and equipment                 0 0  
Stock-based compensation     (1,263)     (773) (241)   2,019 1,085 917
Non-cash interest expense     0     0 0   0 0 0
Non-cash lease expense     0                
Provision recorded for allowance for doubtful accounts           0 0   0 0 0
Loss on extinguishment of debt       0 0   0   0 0 0
Change in fair value of derivative liability       0 0 0 0   0 0  
Change in fair value of common stock warrant liability       0 0 0 0   0 0  
Change in fair value of contingent earn-out liability     1,148 (791)         (791) (1,148)  
Change in fair value of contingently issuable common stock liability     0 0         0 0  
Change in fair value of public warrant liability     0 0         0 0  
Changes in operating assets and liabilities                      
Accounts receivable     0     0 0   0 0 0
Inventory     5,675     (47) 720   10,100 14,043 1,156
Commission assets     0     0 0   0 0 0
Contract assets     0     0 0   (895) 0  
Other assets     141     7 13   23 32 (173)
Prepaid expenses and other current assets     (291)     377 208   1,237 931 (641)
Accounts payable     1,012     (235) (1,862)   (2,024) 772 (1,100)
Deferred revenue     (201)     (185) (100)   (107) (136) 45
Deferred rent     468     0 0   0 0 0
Warranty reserve             0   0 0 0
Accrued expenses and other current liabilities           206 281   651 (2,702) 483
Accrued expenses and other current liabilities     (368)                
Operating lease liability     (468)               0
Net cash used in operating activities     6,437     (401) (1,338)   7,912 12,847 (348)
Cash flows from investing activities:                      
Development of internal-use software     (82)             0  
Purchases of property and equipment     (6,366)     401 1,338   (7,912) (12,847) 348
Net cash used in investing activities     (6,448)     401 1,338   (7,912) (12,847) 348
Cash flows from financing activities:                      
Proceeds from issuance of Series B-1 convertible preferred stock, net of issuance costs                     0
Proceeds from exercise of stock options     11     0 0   0 0 0
Proceeds from issuance of common stock from the PIPE Investment                 0 0  
Proceeds from the closing of the Merger                 0 0  
Payment of offering costs from the closing of the Merger and PIPE Investment                 0 0  
Repayment of financing obligations           0 0   0 0 0
Proceeds from long-term debt, net of issuance costs           0 0   0 0 0
Repayment of principal on long-term debt                   0 0
Net cash provided by (used in) financing activities     11     0 0   0 0 0
Net increase (decrease) in cash, cash equivalents and restricted cash     0     0 0   0 0 0
Cash, cash equivalents and restricted cash                      
Cash, cash equivalents and restricted cash at beginning of period   $ 0 0 0 0 0 0 $ 0 0 0 0
Cash, cash equivalents and restricted cash at end of period     0 $ 0 $ 0 0 0   0 0 0
Supplemental disclosure of cash flow information                      
Transfer of inventory to property and equipment     (4,620)       0   (9,648) (12,949) 0
Capital expenditures incurred but not yet paid     $ 698     1,335 2,962   3,123 2,589 1,100
Capitalization of stock compensation             $ 27        
Issuance of equity classified warrants           $ 0       (1) 0
Deferred offering costs included in accounts payable                 10 11  
Conversion of convertible preferred stock to common stock                 0 0  
Initial fair value of contingent earn-out liability recognized in connection with the closing of the Merger                 176 0  
Initial fair value of contingently issuable common stock liability recognized in connection with the closing of the Merger                 0 0  
Conversion of common stock warrants to common stock in connection with the closing of the Merger                 0 0  
Initial fair value of public warrants in connection with the closing of the Merger                 $ 0 $ 0  
Issuance of a nonrecourse promissory note with officer                     $ 0